Fan Li

Fan Li

Auto-generated profile, based on publicly available information

Fan Li

Department of Respiratory and Critical Care, Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 201600, China;Songjiang District Central Hospital, Shanghai, China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2018 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
ZZZhiyu Zhang
Zhiyu Zhang
HSHao Suo
Hao Suo
XZXiaoqi Zhao
Xiaoqi Zhao
DSDan Sun
Dan Sun
LFLi Fan
Li Fan
CGChongfeng Guo
Chongfeng Guo

10 May 2024 in npj Primary Care Respiratory Medicine
Verified
Journal Article
Open access
PDF file
PWPeng Wu
Peng Wu
YJYi-Qun Jiang
Yi-Qun Jiang
FSFeng-Li Si
Feng-Li Si
HWHuan-Ying Wang
Huan-Ying Wang
XSXiao-Bo Song
Xiao-Bo Song
JZJing Zhang
Jing Zhang
This study aimed to investigate the real-world standardisation and adherence of medical treatment regimens in patients with chronic obstructive pulmonary disease (COPD) in the community for making future management strategy. The follow-up data and treatment information of patients with COPD, which were collected through the Management Information Center of COPD (MICCOPD) in 21 community health service centres in Songjiang District, a countryside region of Shanghai. Concordance between the pharmaceutical treatment plan and recommendation of 2017 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report during the follow-up management period, as well as the medication adherence by patients,were analysed. Out of the 2044 patients diagnosed with COPD, 814 patients (39.8%) who had an initial record of medication use were found to meet the inclusion criteria. The most common medication regimens were long-acting beta-agonist plus inhaled corticosteroids (35.9%) and oral bronchodilators (41.9%). Among these 814 patients, 45.7%, 38.0%, 31.6% and 14.6% adhered to the treatment after 6, 12, 18 and 24 months of follow-up, respectively. The concordance rate with the regimens recommended by the 2017 GOLD guidelines was 35.5% at baseline, 35.5% at 6 months, 32.7% at 12 months, 35.4% at 18 months and 37% at 24 months. The compliance and guideline consistency rates of patients with COPD in the community under the management of general practitioners need to be improved. Enhancing general practitioner proficiency in the prevention and management of COPD and increasing patient awareness of the condition, are crucial standardising and improving adherence to initial and follow-up COPD treatments.

1 March 2023 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
TWTing-Ting Wu
Ting-Ting Wu
YJYi Qun Jiang
Yi Qun Jiang
BZBang-Feng Zhao
Bang-Feng Zhao
FSFeng-Li Si
Feng-Li Si
PWPeng Wu
Peng Wu
JZJing Zhang
Jing Zhang
Objective: To evaluate the real-world situation for the management of chronic obstructive pulmonary disease (COPD) and poorly controlled disease risk factors in the Chinese community. Methods: This retrospective multicentre study analysed data from COPDMICand MICHC in Shanghai Songjiang District, Shanghai, China. The differences in COPD Assessment Test (CAT), the modified Medical Research Council (mMRC) dyspnea scale, and the number of emergency cases, emergency visits, inpatient cases, and hospitalisations from January 2018 to December 2020 were analysed. The impact of coronavirus disease 2019 (COVID-19) on COPD management was also assessed. Results: For 2020 versus 2018, analysis of 468 COPD cases from COPDMIC matched with MICHC data showed significantly more patients with improved mMRC grades, significantly fewer emergency cases and emergency visits, and significantly fewer hospitalisation cases and hospitalisations. Differences in the number of emergency visits and hospitalisations per capita were statistically significant. Compared to GOLD 3– 4, GOLD 1– 2 patients showed significant improvements in CAT score, mMRC grade, the number of emergency visits and hospitalisations per capita. Treatment adherence from 2018 to 2020 was 25%, 29.1%, and 6.8%, and the proportion of medication regimens consistent with guidelines was 43.44%, 50.98%, and 71.87%, respectively. Higher treatment adherence resulted in significantly improved CAT scores and mMRC grades and fewer emergency department visits and hospitalisations per capita. Conclusion: Combined with remote management tools, patients with COPD achieved continuous improvement in symptoms and exacerbations over 3 years. In the context of COVID-19 prevention/control measures, improvements were significant for patients with GOLD 1– 2 COPD but limited with GOLD 3– 4. Pharmacologic treatment significantly improved clinical symptoms and reduced emergency visits and hospitalisations. Severe airflow limitation and poor adherence to pharmacologic treatment were important risk factors for lack of disease remission.

20 November 2020 in The Clinical Respiratory Journal
Verified
Journal Article
Closed access
PDF file
SWSheng‐Mei Wang
Sheng‐Mei Wang
FZFeng‐Ying Zhang
Feng‐Ying Zhang
CDChunling Du
Chunling Du
XWXiong‐Biao Wang
Xiong‐Biao Wang
FLFan Li
Fan Li
SUShanghai Respiratory Society The Shanghai Primary Respiratory Care Union
Shanghai Respiratory Society The Shanghai Primary Respiratory Care Union

1 July 2015 in Journal of Biomaterials and Tissue Engineering
Verified
Journal Article
Closed access
ALAi-Jun Liu
Ai-Jun Liu
XCXingye Chen
Xingye Chen
YHYi Hua
Yi Hua
FLFan Li
Fan Li
DCDong-Feng Chen
Dong-Feng Chen

1 November 2022 in The Journal of Rheumatology
Verified
Journal Article
Open access
PDF file
JDJinghong Dai
Jinghong Dai
LFLi Fan
Li Fan
We thank Wang et al1 for their interest and suggestions on our study on melanoma differentiation–associated gene 5-related interstitial lung disease (MDA5-ILD), which highlighted that tofacitinib (TOF) use might have a potential effect on improving the outcomes of MDA5-ILD.2 We completely agree with their valuable suggestions.